Join Dr. Peter Diamandis on this 5-Day, 5-Star Platinum Longevity Trip
Melanie Ott, MD, PhD
Director, Gladstone Institute of Virology
David Sinclair
Co-Director, Glenn Center for Aging Research, Professor at Harvard Medical School
Eric Verdin, MD
President and CEO, Buck Institute for Research on Aging
George Church PhD
Founding Core Faculty & Lead, Wyss Institute at Harvard University
Mary Lou Jepsen, PhD
CEO and Founder, OpenWater
Shinya Yamanaka, MD, PhD
Nobel Prize laureate & L.K. Whittier Foundation Investigator in Stem Cell Biology, Gladstone Institutes
Jennifer Garrison, PhD
Co-Founder & Director, Global Consortium for Reproductive Longevity & Equality
Sandra Kaufmann, MD
Author and Creator of the Kaufmann Protocol
Timothy Nelson, MD, PhD
Founder & CEO, Heartworks
Alessandra Zonari, PhD
Co-Founder and Chief Scientific Officer, OneSkin
Robin Mansukhani
CEO and Co-Founder, Deciduous Therapeutics
Kyle Zagrodsky
Founder & CEO, OsteoStrong Franchising
Joshua Ofman, MD, MSHS
President and Chief Medical Officer
Daniel Kraft, MD
Founder & Chair, Exponential Medicine
Josh Clemente
Founder, Levels
Jon Carder
Co-Founder & CEO, Vessel Health
Dr. Trevor Martin
Co Founder, Mammoth Biosciences
Kristen Fortney, PhD
Co Founder and CEO, BioAge
Naveen Jain
Author, Moonshots: Creating a World of Abundance
Morgan Levine, PhD
Founding Principal Investigator, Altos Labs
Daniel Oliver
Co Founder and CEO, Rejuvenate Bio
Dean Ornish, MD
Founder and President, Preventive Medicine Research Institute
Priya Abani
CEO, President, and Board Member, AliveCor
James Min, MD
Founder and CEO, Cleerly
Katerina Akassoglou, PhD
Professor of Neurology, UC San Francisco (UCSF)
Yadong Huang, MD, PhD
Scientific Co-Founder, GABAeron
James Nestor
Science Journalist and Author, Breath
Tara Tracy, PhD
Assistant Professor, Buck Institute for Research on Aging
Seth Shipman, PHD
Assistant Professor, Gladstone Institutes at UCSF
George Shapiro, MD
Chief Medical Innovation Officer, Fountain Life
Matt Walker, PhD
Professor, UC Berkeley
Bjoern Woltermann
Founder & CEO, Katalyst
Denitsa Milanova, PhD
Fellow & PI, Marble Therapeutics
Sandeep Akkaraju
CEO & President, Exo Imaging
Greg Bailey, MD
CEO, Juvenescence
Hector L. LopezMD, CSCS, FAAPMR
Chief Research and Innovation Advisor, LIFEFORCE
Carolina Reis
CEO, OneSkin
Leor Weinberger, PhD
Co-Founder, VxBiosciences
John Jaquish, PhD
Inventor, OsteoStrong Devices
Kenneth R. Brown, DDS
Co-Founder & CEO, Feno
David Furman, PhD
Associate Professor, Buck Institute for Research on Aging
Isha Jain, PhD
Assistant Professor, Gladstone Institutes and UCSF
Kyle Zagrodzky
Founder & CEO, OsteoStrong Franchising
Deepak Srivastava, MD
President, Gladstone Institutes
David Fagjenbaum, MD
Physician-Scientist, University of Pennsylvania
Brianna Stubbs, PhD
Lead Translational Scientist, Buck Institute for Research on Aging
Noah Davidsohn, PhD
CSO, Co-Founder, Rejuvenate Bio
Kent Wakeford
Co Founder, Chief Operating Officer, Colossal
Alex Aravanis MD PhD
Chief Technology Officer, Illumina
Remy Gross III
Vice President, Business Development and Technology Advancement, Buck Institute for Research on Aging
Longevity & Biotech Topics
Delve into the next decade of longevity and biotechnology innovations across:
The 2023 Platinum Longevity Trip is a luxury 5-day deep dive into the future of your health, spanning key therapies, research, and novel breakthroughs that will define the next decade of longevity: regenerative medicine and stem cell therapies, advancements in brain health and prevention of neurodegenerative diseases, CRISPR and gene therapies, senolytic medicines, advanced diagnostics, and others.
The trip offers first-hand exposure to the pioneering founders, scientists, startups, public biotech companies and treatments in longevity and vitality. Gain an exclusive view of what is coming our way this next decade in personalized, preventive medicine, and rejuvenation treatments.

High-Level details
What's Included
5-star accommodation
Private charter service & all internal transit
Haute cuisine menus
Wellness treatments
Advanced diagnostics
Cost
Individual Rate: $70,000
Couple's Rate: $65,000 / person


Personalized for 40 extraordinary people
Limited to an exclusive group of serious players (C-suite executives, investors, industry leaders) worldwide, Abundance Platinum is about fostering lifelong friendships.
Our group will additionally be joined by resident longevity experts that will accompany and advise members throughout the trip.
Through a personalization process, Peter and his team work to determine what therapies, health concerns (involving family medical history), investment interests, and conditions are most important to you. The experience is then curated through our various symposiums, featured treatments, and hosted experts to emphasize your most pressing interests.
Trip overview by topic
Day 0
Itinerary
- Arrive in San Francisco
- Check in: St. Regis San Francisco
Day 1
Topics
- Gene Therapy
- Young Blood & GDF11
- Brain-Immune-Gut Axis
- CRISPR & Genetic Engineering
Day 2
Topics
- Tissue Engineering
- Sensors & Wearables
- COVID-19 & Future of Pandemics
- Regenerative Medicine
- Brain Health
Day 3
Topics
- Neurodegenerative Diseases
- Cardiovascular Health
- Oncology & Cancer Therapies
- NAD+ / Sirtuins Diagnostics Biofabrication
Day 4
Itinerary
- Flight to San Diego
- Check in: Park Hyatt Aviara
Topics
- Biological Mechanics of Aging
- Cellular Therapies
Day 5
Topics
- Stem Cells
- Drug Discovery: Age-Related Diseases
- Organ Procurement
- The Future of Aging
- Closing Reception
Join Us on Our Next Abundance Platinum Trip
Trip #1: Aug 16-20, 2023 | Trip #2: Sep 27- Oct 01, 2023
Message from Peter H. Diamandis, MD
My mission is to transform your mindset around longevity. To give you overwhelming evidence of the massive medical advancements that are already beginning to extend the human healthspan.
Now more than ever, during a period of exponential medicine, you don’t have to accept the cards you’re dealt. Technologies like genome sequencing, RNA transcriptomics, Wnt pathway modifiers, vaccines, CRISPR, liquid biopsies, CAR-T cells, Gene Therapy, exosomes, and stem cells are just a few of the technologies under development. My goal through these 5 days is to fundamentally reframe your concept of aging as a disease -- a disease that many are beginning to believe can be slowed, stopped and perhaps even reversed.
About Peter
Fortune Magazine named Diamandis as one of the World’s 50 Greatest Leaders. He is the Founder & Executive Chairman of the XPRIZE Foundation and Executive Founder of Singularity University and has co-Founded 20 companies including Celularity, Human Longevity Inc., and BOLD Capital Partners. Diamandis is the NY Times Bestselling author of Abundance and BOLD. He earned degrees in Molecular Genetics and Aerospace Engineering from MIT, and an MD from Harvard Medical School.